SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-051834
Filing Date
2019-09-27
Accepted
2019-09-27 17:31:04
Documents
4
Period of Report
2019-09-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-18930_38k.htm 8-K 29781
2 EX-1.1 a19-18930_3ex1d1.htm EX-1.1 260117
3 EX-5.1 a19-18930_3ex5d1.htm EX-5.1 20523
4 GRAPHIC g189303kki001.gif GRAPHIC 2825
  Complete submission text file 0001104659-19-051834.txt   315520
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 191123165
SIC: 2834 Pharmaceutical Preparations